Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes

Ashley Spann, Christopher Coe, Teminioluwa Ajayi, Garren Montgomery, Mohammed Shwetar, Adesola Oje, Jeffrey Annis, James C. Slaughter, Sophoclis Alexopoulos, Evan Brittain, Manhal Izzy – 24 March 2022 – Cardiovascular disease (CVD) significantly contributes to morbidity and mortality after liver transplantation (LT). Cirrhotic cardiomyopathy (CCM) is a risk factor for CVD after transplant. CCM criteria were originally introduced in 2005 with a revision proposed in 2020 reflecting echocardiographic technology advancements.

Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score

Rish K. Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A. Adeyi, Quentin M. Anstee, Bashar A. Aqel, Cynthia Behling, Elizabeth J. Carey, Andrew D. Clouston, Kathleen Corey, Brian G. Feagan, David E. Kleiner, Christopher Ma, Stefanie C. McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A. Valasek, Zobair M. Younossi, Stephen A. Harrison, Rohit Loomba – 24 March 2022

Reply

Vladimir V. Loukachov, Karel A. Dort, Robin Erken, Henk W. Reesink, Neeltje A. Kootstra – 22 March 2022

Subscribe to